Asklepion Pharmaceuticals
Manufacturing · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
729 E Pratt St Ste 360, Baltimore, Maryl...Phone Number
(410) 545-0494Website
www.asklepionpharm.comRevenue
<$5 MillionIndustry
About Asklepion Pharmaceuticals
Asklepion Pharmaceuticals, LLC is a pharmaceutical development company dedicated to the discovery, development, and commercialization of products aimed at patients with rare diseases, particularly children who have limited therapeutic options. The company focuses on innovative treatments, including intravenous citrulline for pediatric patients undergoing cardiopulmonary bypass. Asklepion has received recognition for its contributions to rare disease treatment, including Orphan Drug Designation from the U.S. FDA. Their mission is to provide effective treatment options for those affected by rare conditions.Explore more
Asklepion Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Asklepion Pharmaceuticals
Compare insights from companies similar to Asklepion Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Asklepion Pharmaceuticals Tech Stack
A closer look at the technologies used by Asklepion Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Asklepion Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Asklepion Pharmaceuticals, LLC is a pharmaceutical development company dedicated to the discovery, development, and commercialization of products aimed at patients with rare diseases, particularly children who have limited therapeutic options. The company focuses on innovative treatments, including intravenous citrulline for pediatric patients unde... Read More
